Clinical Trial Update: Nepafenac Once Daily for Macular Edema - Study 2 [Phase 3]

View source ↗

Summary

Phase 3 study update for nepafenac once-daily in macular edema with non-proliferative diabetic retinopathy or cataract; completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract
• Non-proliferative Diabetic Retinopathy

Drugs mentioned

• Nepafenac (nepafenac)

Snippet

Sponsor: Alcon Research | Conditions: Non-Proliferative Diabetic Retinopathy, Cataract | Phase 3 | Status: COMPLETED | Results posted: 2016-08-02